alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,976–7,000 of 7,816 matching trials · page 280 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
NCT01626391
TRx0237; Placebo
Runs in: Germany; United Kingdom · 12 sites 		PHASE2
other		 TERMINATED 9 TauRx Therapeutics Ltd
INDUSTRY		 2014-07-11
Experimental Study to Validate the "Therapeutic Game" CONEM-BETA
NCT01652222
CONEM-BETA + socio-educational training; Socio-educational training only
Runs in: Spain · 3 sites 		NA
other		 COMPLETED 101 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
OTHER		 2014-07-09
Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients
NCT01762618
Cognitive Behavioral Therapy Group
Runs in: Spain · 3 sites 		NA
other		 COMPLETED 83 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
OTHER		 2014-07-09
Alzheimer and Sleep
NCT00750529
Galantamine and Donepezil
Runs in: France · 2 sites 		PHASE1
symptomatic-cholinergic		 COMPLETED 15 University Hospital, Clermont-Ferrand
OTHER		 2014-07-08
AZD3293 Thorough QT Study in Healthy Male Volunteers
NCT02040987
AZD3293; AZD3293; Placebo; Moxifloxacin
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 52 AstraZeneca
INDUSTRY		 2014-07-03
Delta-THC in Dementia
NCT01608217
delta-9-tetrahydrocannabinol (delta-THC); Placebo; Acetaminophen; A...
Runs in: Netherlands · 2 sites 		PHASE2
other		 COMPLETED 50 Radboud University Medical Center
OTHER		 2014-06-30
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
NCT01860625
Donepezil patch; placebo
Runs in: South Korea · 1 site 		PHASE1
symptomatic-cholinergic		 COMPLETED 36 Icure Pharmaceutical Inc.
INDUSTRY		 2014-06-30
Citalopram for Agitation in Alzheimer's Disease
NCT00898807
citalopram; placebo
Runs in: Canada; United States · 8 sites 		PHASE3
other		 COMPLETED 186 JHSPH Center for Clinical Trials
OTHER		 2014-06-27
Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients
NCT01138111
Florbetaben (BAY94-9172)
Runs in: Australia · 1 site 		PHASE1
other		 COMPLETED 45 Lantheus Biosciences Ltd.
INDUSTRY		 2014-06-25
Reducing Depression in Dementia Caregivers
NCT00056316
Basic Education; Behavioral Skills Training: Experimental
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 COMPLETED 74 University of Missouri, St. Louis
OTHER		 2014-06-23
Small Doses of Dexmedetomidine for Emergence Agitation
NCT02169843
Sevoflurane; Dexmedetomidine; Placebo(for Dexmedetomidine)
Runs in: China · 1 site 		PHASE4
other		 UNKNOWN 80 Tang-Du Hospital
OTHER		 2014-06-23
AST-120 Used to Treat Mild Hepatic Encephalopathy
NCT00867698
AST-120
Runs in: United States · 38 sites 		PHASE2
other		 COMPLETED 148 Ocera Therapeutics
INDUSTRY		 2014-06-18
Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
NCT01009476
Galantamine; Nootropics (ginkgo biloba, nicergoline, piracetam, or others) 		NA
symptomatic-cholinergic		 COMPLETED 1,134 Janssen-Cilag G.m.b.H
INDUSTRY		 2014-06-18
Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.
NCT02164773
Magnesium Sulfate; 0.9%normal saline
Runs in: Egypt · 1 site 		PHASE4
other		 UNKNOWN 70 Ain Shams University
OTHER		 2014-06-17
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
NCT02126514
AZD3293
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 12 AstraZeneca
INDUSTRY		 2014-06-16
Progression Delaying Effect of Escitalopram in Alzheimer's Disease
NCT00702780
escitalopram; placebo
Runs in: South Korea · 4 sites 		NA
other		 COMPLETED 74 Seoul National University Hospital
OTHER		 2014-06-13
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
NCT00428389
Rivastigmine 5 cm^2 transdermal patch; Rivastigmine 10 cm^2 transde...
Runs in: United States · 23 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 262 Novartis
INDUSTRY		 2014-06-11
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
NCT00183092
Quinacrine; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 69 University of California, San Francisco
OTHER		 2014-06-09
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
NCT00198055
aripiprazole
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 25 Indiana University
OTHER		 2014-06-04
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01028911
PF-03654746; Placebo
Runs in: United States · 2 sites 		PHASE1
other		 TERMINATED 9 Pfizer
INDUSTRY		 2014-06-04
Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
NCT01461109
[18F] CFPyPB
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 4 Institute for Neurodegenerative Disorders
OTHER		 2014-06-04
Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)
NCT02149017
SNUBH-NM-333(18F)
Runs in: South Korea · 1 site 		PHASE1|PHASE2
other		 TERMINATED 30 Seoul National University Hospital
OTHER		 2014-05-29
An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
NCT00299676
Galantamine (Reminyl)
Runs in: Australia · 5 sites 		NA
symptomatic-cholinergic		 COMPLETED 61 Janssen-Cilag Pty Ltd
INDUSTRY		 2014-05-23
A Study on Behavioral and Psychological Symptoms of Dementia
NCT00641459
Observational BPSD treatment study 		NA
other		 COMPLETED 359 Johnson & Johnson Taiwan Ltd
INDUSTRY		 2014-05-23
Memory Aid - Working Memory Training in Patients With Mild Cognitive Impairment.
NCT01991405
Computerized Working Memory Training.
Runs in: Norway · 1 site 		NA
other		 UNKNOWN 90 Sorlandet Hospital HF
OTHER_GOV		 2014-05-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →